Upon completion of this activity, participants should be able to:

Identify key updates in the management of atrial fibrillation from the 2023 ACC AHA ACCP HRS guidelines.

Define the role of conduction system pacing in clinical practice.

Summarize viability testing in patients with ischemic cardiomyopathy.

Present data behind interventions for chronic total occlusions.

Describe the efficacy of various diets for the patients of cardiovascular disease.

Assess mitral valve structural interventions currently used in clinical practice.

Illustrate a guideline-based approach to the management of aortopathies.

Formulate an approach to diagnosing various forms of cardiac amyloid.

Summarize current guideline-based practice for the diagnosis of pulmonary hypertension.

Describe an approach to the use of effective non-statin therapies for lipid lowering in challenging cases of hypercholesterolemia.

Prices:
General Admission for M.D., D.O., Ph.D.: USD 995.00,
Earlybird for M.D., D.O., Ph.D.: USD 895.00,
General Admission for Allied Health, NP, PA, Residents, Fellows, Retirees: USD 795.00,
Earlybird for Allied Health, NP, PA, Residents, Fellows, Retirees: USD 695.00

Speakers: Luis R. Scott, M.D., Carolyn M. Larsen, M.D., Eric H. Yang, M.D.